表紙
市場調查報告書

硬化療法的全球市場:各藥物 (清洗性硬化劑,滲透性硬化劑,化學性刺激性硬化劑)、各類型 (液體硬化療法,超音波硬化療法,泡沫硬化療法)、各地區的產業分析與未來預測 (2020∼2026年)

Global Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Region, Industry Analysis and Forecast, 2020 - 2026

出版商 KBV Research 商品編碼 969208
出版日期 內容資訊 英文 132 Pages
訂單完成後即時交付
價格
硬化療法的全球市場:各藥物 (清洗性硬化劑,滲透性硬化劑,化學性刺激性硬化劑)、各類型 (液體硬化療法,超音波硬化療法,泡沫硬化療法)、各地區的產業分析與未來預測 (2020∼2026年) Global Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Region, Industry Analysis and Forecast, 2020 - 2026
出版日期: 2020年10月31日內容資訊: 英文 132 Pages
簡介

全球硬化療法的市場規模,預計今後以7.9%的年複合成長率持續擴大,至2026年達到12億美元。

本報告提供全球硬化療法的市場相關分析,疾病、治療方法概要和市場主要趨勢,市場規模趨勢預測 (今後7年份),各藥物、各類型及各地區詳細趨勢,主要的推動及阻礙市場要素,主要企業的簡介等資訊彙整,為您概述為以下內容。

目錄

第1章 市場範圍和分析方法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 全球硬化療法市場:各藥物

  • 清洗性硬化劑
  • 滲透性硬化劑
  • 化學的刺激性硬化劑

第4章 全球硬化療法市場:各類型

  • 液狀硬化療法
  • 超音波硬化療法
  • 其他的種類

第5章 全球硬化療法市場:各地區

  • 北美市場
  • 歐洲市場
  • 亞太地區市場
  • 南美、中東、非洲 (LAMEA) 市場

第6章 企業簡介

  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang'an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG
目錄

The Global Sclerotherapy Market size is expected to reach $1.2 billion by 2026, rising at a market growth of 7.9% CAGR during the forecast period. Sclerotherapy is a less invasive treatment that are used in treatment of varicose veins. The procedure involves the injection of a sclerosing agent's solution directly into the affected veins, resulting in their shrink and they eventually get disappeared. It is medical procedure that are useful for the treatment of blood vessel and lymphatic system malformations.

The sclerotherapy is usually used to treat spider veins, haemorrhoids, and smaller varicose veins in adults. In Sclerotherapy, a very fine and thin injection needle is used to inject solution in order to treat small varicose veins in the legs, improve the appearance of spider veins, and get rid of related symptoms like burning, aching, swelling and cramping. Dermatologists have played an important role in the advancement of new safe, and non-invasive technologies that can be use in the treatment of both larger varicose veins, and cosmetic telangiectasias and procedure has become a medical significance. The major advancements have been made in sclerosing solutions, and endovascular RF and laser procedures and they have brought a revolution in the healthcare industry.

In the current scenario, more respected hospital is preferring to opt for minimally invasive surgical procedure including Sclerotherapy Treatment. Sclerosing agents that are used for the varicose veins treatment is segmented into detergents, chemical irritants, and hyperosmolar/ osmotic agents. Agents such as Sodium morrhuate (Scleromate), Sodium tetradecyl sulfate (Sotradecol) and Polidocanol (Asclera), Ethanolamine Oleate (Ethamoline) are approved by FDA therefore these sclerosants are used to treat and decrease the effect of vein damage. As per the Society of Vascular surgery, around 33.0% of women and more than 17.0% of men refer a doctor for varicose veins, and telangiectasias in developed countries, that has affected up to 35.0% of people in the U.S.

Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang'an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.

Scope of the Study

Market Segmentation:

By Agent

  • Detergents
  • Osmotic Agents
  • Chemical Irritants

By Type

  • Liquid Sclerotherapy
  • Ultrasound Sclerotherapy
  • Foam Sclerotherapy

By Geography

  • North America

US

Canada

Mexico

Rest of North America

  • Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

  • Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

  • LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang'an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Sclerotherapy Market, by Agent
    • 1.4.2 Global Sclerotherapy Market, by Type
    • 1.4.3 Global Sclerotherapy Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Sclerotherapy Market by Agent

  • 3.1 Global Detergents Market by Region
  • 3.2 Global Osmotic Agents Market by Region
  • 3.3 Global Chemical Irritants Market by Region

Chapter 4. Global Sclerotherapy Market by Type

  • 4.1 Global Liquid Sclerotherapy Market by Region
  • 4.2 Global Ultrasound Sclerotherapy Market by Region
  • 4.3 Global Other Type Market by Region

Chapter 5. Global Sclerotherapy Market by Region

  • 5.1 North America Sclerotherapy Market
    • 5.1.1 North America Sclerotherapy Market by Agent
      • 5.1.1.1 North America Detergents Market by Country
      • 5.1.1.2 North America Osmotic Agents Market by Country
      • 5.1.1.3 North America Chemical Irritants Market by Country
    • 5.1.2 North America Sclerotherapy Market by Type
      • 5.1.2.1 North America Liquid Sclerotherapy Market by Country
      • 5.1.2.2 North America Ultrasound Sclerotherapy Market by Country
      • 5.1.2.3 North America Other Type Market by Country
    • 5.1.3 North America Sclerotherapy Market by Country
      • 5.1.3.1 US Sclerotherapy Market
        • 5.1.3.1.1 US Sclerotherapy Market by Agent
        • 5.1.3.1.2 US Sclerotherapy Market by Type
      • 5.1.3.2 Canada Sclerotherapy Market
        • 5.1.3.2.1 Canada Sclerotherapy Market by Agent
        • 5.1.3.2.2 Canada Sclerotherapy Market by Type
      • 5.1.3.3 Mexico Sclerotherapy Market
        • 5.1.3.3.1 Mexico Sclerotherapy Market by Agent
        • 5.1.3.3.2 Mexico Sclerotherapy Market by Type
      • 5.1.3.4 Rest of North America Sclerotherapy Market
        • 5.1.3.4.1 Rest of North America Sclerotherapy Market by Agent
        • 5.1.3.4.2 Rest of North America Sclerotherapy Market by Type
  • 5.2 Europe Sclerotherapy Market
    • 5.2.1 Europe Sclerotherapy Market by Agent
      • 5.2.1.1 Europe Detergents Market by Country
      • 5.2.1.2 Europe Osmotic Agents Market by Country
      • 5.2.1.3 Europe Chemical Irritants Market by Country
    • 5.2.2 Europe Sclerotherapy Market by Type
      • 5.2.2.1 Europe Liquid Sclerotherapy Market by Country
      • 5.2.2.2 Europe Ultrasound Sclerotherapy Market by Country
      • 5.2.2.3 Europe Other Type Market by Country
    • 5.2.3 Europe Sclerotherapy Market by Country
      • 5.2.3.1 Germany Sclerotherapy Market
        • 5.2.3.1.1 Germany Sclerotherapy Market by Agent
        • 5.2.3.1.2 Germany Sclerotherapy Market by Type
      • 5.2.3.2 UK Sclerotherapy Market
        • 5.2.3.2.1 UK Sclerotherapy Market by Agent
        • 5.2.3.2.2 UK Sclerotherapy Market by Type
      • 5.2.3.3 France Sclerotherapy Market
        • 5.2.3.3.1 France Sclerotherapy Market by Agent
        • 5.2.3.3.2 France Sclerotherapy Market by Type
      • 5.2.3.4 Russia Sclerotherapy Market
        • 5.2.3.4.1 Russia Sclerotherapy Market by Agent
        • 5.2.3.4.2 Russia Sclerotherapy Market by Type
      • 5.2.3.5 Spain Sclerotherapy Market
        • 5.2.3.5.1 Spain Sclerotherapy Market by Agent
        • 5.2.3.5.2 Spain Sclerotherapy Market by Type
      • 5.2.3.6 Italy Sclerotherapy Market
        • 5.2.3.6.1 Italy Sclerotherapy Market by Agent
        • 5.2.3.6.2 Italy Sclerotherapy Market by Type
      • 5.2.3.7 Rest of Europe Sclerotherapy Market
        • 5.2.3.7.1 Rest of Europe Sclerotherapy Market by Agent
        • 5.2.3.7.2 Rest of Europe Sclerotherapy Market by Type
  • 5.3 Asia Pacific Sclerotherapy Market
    • 5.3.1 Asia Pacific Sclerotherapy Market by Agent
      • 5.3.1.1 Asia Pacific Detergents Market by Country
      • 5.3.1.2 Asia Pacific Osmotic Agents Market by Country
      • 5.3.1.3 Asia Pacific Chemical Irritants Market by Country
    • 5.3.2 Asia Pacific Sclerotherapy Market by Type
      • 5.3.2.1 Asia Pacific Liquid Sclerotherapy Market by Country
      • 5.3.2.2 Asia Pacific Ultrasound Sclerotherapy Market by Country
      • 5.3.2.3 Asia Pacific Other Type Market by Country
    • 5.3.3 Asia Pacific Sclerotherapy Market by Country
      • 5.3.3.1 China Sclerotherapy Market
        • 5.3.3.1.1 China Sclerotherapy Market by Agent
        • 5.3.3.1.2 China Sclerotherapy Market by Type
      • 5.3.3.2 Japan Sclerotherapy Market
        • 5.3.3.2.1 Japan Sclerotherapy Market by Agent
        • 5.3.3.2.2 Japan Sclerotherapy Market by Type
      • 5.3.3.3 India Sclerotherapy Market
        • 5.3.3.3.1 India Sclerotherapy Market by Agent
        • 5.3.3.3.2 India Sclerotherapy Market by Type
      • 5.3.3.4 South Korea Sclerotherapy Market
        • 5.3.3.4.1 South Korea Sclerotherapy Market by Agent
        • 5.3.3.4.2 South Korea Sclerotherapy Market by Type
      • 5.3.3.5 Singapore Sclerotherapy Market
        • 5.3.3.5.1 Singapore Sclerotherapy Market by Agent
        • 5.3.3.5.2 Singapore Sclerotherapy Market by Type
      • 5.3.3.6 Malaysia Sclerotherapy Market
        • 5.3.3.6.1 Malaysia Sclerotherapy Market by Agent
        • 5.3.3.6.2 Malaysia Sclerotherapy Market by Type
      • 5.3.3.7 Rest of Asia Pacific Sclerotherapy Market
        • 5.3.3.7.1 Rest of Asia Pacific Sclerotherapy Market by Agent
        • 5.3.3.7.2 Rest of Asia Pacific Sclerotherapy Market by Type
  • 5.4 LAMEA Sclerotherapy Market
    • 5.4.1 LAMEA Sclerotherapy Market by Agent
      • 5.4.1.1 LAMEA Detergents Market by Country
      • 5.4.1.2 LAMEA Osmotic Agents Market by Country
      • 5.4.1.3 LAMEA Chemical Irritants Market by Country
    • 5.4.2 LAMEA Sclerotherapy Market by Type
      • 5.4.2.1 LAMEA Liquid Sclerotherapy Market by Country
      • 5.4.2.2 LAMEA Ultrasound Sclerotherapy Market by Country
      • 5.4.2.3 LAMEA Other Type Market by Country
    • 5.4.3 LAMEA Sclerotherapy Market by Country
      • 5.4.3.1 Brazil Sclerotherapy Market
        • 5.4.3.1.1 Brazil Sclerotherapy Market by Agent
        • 5.4.3.1.2 Brazil Sclerotherapy Market by Type
      • 5.4.3.2 Argentina Sclerotherapy Market
        • 5.4.3.2.1 Argentina Sclerotherapy Market by Agent
        • 5.4.3.2.2 Argentina Sclerotherapy Market by Type
      • 5.4.3.3 UAE Sclerotherapy Market
        • 5.4.3.3.1 UAE Sclerotherapy Market by Agent
        • 5.4.3.3.2 UAE Sclerotherapy Market by Type
      • 5.4.3.4 Saudi Arabia Sclerotherapy Market
        • 5.4.3.4.1 Saudi Arabia Sclerotherapy Market by Agent
        • 5.4.3.4.2 Saudi Arabia Sclerotherapy Market by Type
      • 5.4.3.5 South Africa Sclerotherapy Market
        • 5.4.3.5.1 South Africa Sclerotherapy Market by Agent
        • 5.4.3.5.2 South Africa Sclerotherapy Market by Type
      • 5.4.3.6 Nigeria Sclerotherapy Market
        • 5.4.3.6.1 Nigeria Sclerotherapy Market by Agent
        • 5.4.3.6.2 Nigeria Sclerotherapy Market by Type
      • 5.4.3.7 Rest of LAMEA Sclerotherapy Market
        • 5.4.3.7.1 Rest of LAMEA Sclerotherapy Market by Agent
        • 5.4.3.7.2 Rest of LAMEA Sclerotherapy Market by Type

Chapter 6. Company Profiles

  • 6.1 Boston Scientific Corporation
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 Perrigo Company PLC (Omega Pharmaceuticals)
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expense
  • 6.3 Cook Medical, Inc. (Cook Group)
    • 6.3.1 Company Overview
  • 6.4 Chemische Fabrik Kreussler & Co. GmbH
    • 6.4.1 Company Overview
  • 6.5 LGM Pharma, LLC
    • 6.5.1 Company Overview
  • 6.6 Troikaa Pharmaceuticals Limited
    • 6.6.1 Company Overview
  • 6.7 Tianyu Chang'an Group
    • 6.7.1 Company Overview
  • 6.8 Endo-Flex GmbH (Meditek Systems)
    • 6.8.1 Company Overview
  • 6.9 Merz Pharma GmbH & Co. KGaA
    • 6.9.1 Company Overview
    • 6.9.2 Recent strategies and developments:
      • 6.9.2.1 Partnerships, Collaborations, and Agreements:
  • 6.10. MTW-Endoskopie W. Haag KG
    • 6.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 GLOBAL SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 GLOBAL SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 GLOBAL SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 4 GLOBAL SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 5 GLOBAL DETERGENTS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 6 GLOBAL DETERGENTS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 7 GLOBAL OSMOTIC AGENTS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 8 GLOBAL OSMOTIC AGENTS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 9 GLOBAL CHEMICAL IRRITANTS MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 10 GLOBAL CHEMICAL IRRITANTS MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 11 GLOBAL SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 12 GLOBAL SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 13 GLOBAL LIQUID SCLEROTHERAPY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 14 GLOBAL LIQUID SCLEROTHERAPY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 15 GLOBAL ULTRASOUND SCLEROTHERAPY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 16 GLOBAL ULTRASOUND SCLEROTHERAPY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 17 GLOBAL OTHER TYPE MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 18 GLOBAL OTHER TYPE MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 19 GLOBAL SCLEROTHERAPY MARKET BY REGION, 2016 - 2019, USD MILLION
  • TABLE 20 GLOBAL SCLEROTHERAPY MARKET BY REGION, 2020 - 2026, USD MILLION
  • TABLE 21 NORTH AMERICA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 22 NORTH AMERICA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 23 NORTH AMERICA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 24 NORTH AMERICA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 25 NORTH AMERICA DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 26 NORTH AMERICA DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 27 NORTH AMERICA OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 28 NORTH AMERICA OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 29 NORTH AMERICA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 30 NORTH AMERICA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 31 NORTH AMERICA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 32 NORTH AMERICA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 33 NORTH AMERICA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 34 NORTH AMERICA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 35 NORTH AMERICA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 36 NORTH AMERICA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 37 NORTH AMERICA OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 38 NORTH AMERICA OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 39 NORTH AMERICA SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 40 NORTH AMERICA SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 41 US SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 42 US SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 43 US SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 44 US SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 45 US SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 46 US SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 47 CANADA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 48 CANADA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 49 CANADA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 50 CANADA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 51 CANADA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 52 CANADA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 53 MEXICO SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 54 MEXICO SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 55 MEXICO SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 56 MEXICO SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 57 MEXICO SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 58 MEXICO SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 59 REST OF NORTH AMERICA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 60 REST OF NORTH AMERICA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 61 REST OF NORTH AMERICA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 62 REST OF NORTH AMERICA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 63 REST OF NORTH AMERICA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 64 REST OF NORTH AMERICA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 65 EUROPE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 66 EUROPE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 67 EUROPE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 68 EUROPE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 69 EUROPE DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 70 EUROPE DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 71 EUROPE OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 72 EUROPE OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 73 EUROPE CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 74 EUROPE CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 75 EUROPE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 76 EUROPE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 77 EUROPE LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 78 EUROPE LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 79 EUROPE ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 80 EUROPE ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 81 EUROPE OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 82 EUROPE OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 83 EUROPE SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 84 EUROPE SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 85 GERMANY SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 86 GERMANY SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 87 GERMANY SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 88 GERMANY SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 89 GERMANY SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 90 GERMANY SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 91 UK SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 92 UK SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 93 UK SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 94 UK SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 95 UK SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 96 UK SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 97 FRANCE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 98 FRANCE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 99 FRANCE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 100 FRANCE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 101 FRANCE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 102 FRANCE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 103 RUSSIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 104 RUSSIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 105 RUSSIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 106 RUSSIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 107 RUSSIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 108 RUSSIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 109 SPAIN SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 110 SPAIN SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 111 SPAIN SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 112 SPAIN SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 113 SPAIN SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 114 SPAIN SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 115 ITALY SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 116 ITALY SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 117 ITALY SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 118 ITALY SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 119 ITALY SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 120 ITALY SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 121 REST OF EUROPE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 122 REST OF EUROPE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 123 REST OF EUROPE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 124 REST OF EUROPE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 125 REST OF EUROPE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 126 REST OF EUROPE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 127 ASIA PACIFIC SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 128 ASIA PACIFIC SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 129 ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 130 ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 131 ASIA PACIFIC DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 132 ASIA PACIFIC DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 133 ASIA PACIFIC OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 134 ASIA PACIFIC OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 135 ASIA PACIFIC CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 136 ASIA PACIFIC CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 137 ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 138 ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 139 ASIA PACIFIC LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 140 ASIA PACIFIC LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 141 ASIA PACIFIC ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 142 ASIA PACIFIC ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 143 ASIA PACIFIC OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 144 ASIA PACIFIC OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 145 ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 146 ASIA PACIFIC SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 147 CHINA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 148 CHINA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 149 CHINA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 150 CHINA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 151 CHINA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 152 CHINA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 153 JAPAN SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 154 JAPAN SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 155 JAPAN SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 156 JAPAN SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 157 JAPAN SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 158 JAPAN SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 159 INDIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 160 INDIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 161 INDIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 162 INDIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 163 INDIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 164 INDIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 165 SOUTH KOREA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 166 SOUTH KOREA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 167 SOUTH KOREA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 168 SOUTH KOREA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 169 SOUTH KOREA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 170 SOUTH KOREA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 171 SINGAPORE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 172 SINGAPORE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 173 SINGAPORE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 174 SINGAPORE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 175 SINGAPORE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 176 SINGAPORE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 177 MALAYSIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 178 MALAYSIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 179 MALAYSIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 180 MALAYSIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 181 MALAYSIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 182 MALAYSIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 183 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 184 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 185 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 186 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 187 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 188 REST OF ASIA PACIFIC SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 189 LAMEA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 190 LAMEA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 191 LAMEA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 192 LAMEA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 193 LAMEA DETERGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 194 LAMEA DETERGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 195 LAMEA OSMOTIC AGENTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 196 LAMEA OSMOTIC AGENTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 197 LAMEA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 198 LAMEA CHEMICAL IRRITANTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 199 LAMEA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 200 LAMEA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 201 LAMEA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 202 LAMEA LIQUID SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 203 LAMEA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 204 LAMEA ULTRASOUND SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 205 LAMEA OTHER TYPE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 206 LAMEA OTHER TYPE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 207 LAMEA SCLEROTHERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 208 LAMEA SCLEROTHERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 209 BRAZIL SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 210 BRAZIL SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 211 BRAZIL SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 212 BRAZIL SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 213 BRAZIL SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 214 BRAZIL SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 215 ARGENTINA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 216 ARGENTINA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 217 ARGENTINA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 218 ARGENTINA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 219 ARGENTINA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 220 ARGENTINA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 221 UAE SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 222 UAE SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 223 UAE SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 224 UAE SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 225 UAE SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 226 UAE SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 227 SAUDI ARABIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 228 SAUDI ARABIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 229 SAUDI ARABIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 230 SAUDI ARABIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 231 SAUDI ARABIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 232 SAUDI ARABIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 233 SOUTH AFRICA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 234 SOUTH AFRICA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 235 SOUTH AFRICA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 236 SOUTH AFRICA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 237 SOUTH AFRICA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 238 SOUTH AFRICA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 239 NIGERIA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 240 NIGERIA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 241 NIGERIA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 242 NIGERIA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 243 NIGERIA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 244 NIGERIA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 245 REST OF LAMEA SCLEROTHERAPY MARKET, 2016 - 2019, USD MILLION
  • TABLE 246 REST OF LAMEA SCLEROTHERAPY MARKET, 2020 - 2026, USD MILLION
  • TABLE 247 REST OF LAMEA SCLEROTHERAPY MARKET BY AGENT, 2016 - 2019, USD MILLION
  • TABLE 248 REST OF LAMEA SCLEROTHERAPY MARKET BY AGENT, 2020 - 2026, USD MILLION
  • TABLE 249 REST OF LAMEA SCLEROTHERAPY MARKET BY TYPE, 2016 - 2019, USD MILLION
  • TABLE 250 REST OF LAMEA SCLEROTHERAPY MARKET BY TYPE, 2020 - 2026, USD MILLION
  • TABLE 251 KEY INFORMATION - BOSTON SCIENTIFIC CORPORATION
  • TABLE 252 KEY INFORMATION - PERRIGO COMPANY PLC
  • TABLE 253 KEY INFORMATION - COOK MEDICAL, INC.
  • TABLE 254 KEY INFORMATION - CHEMISCHE FABRIK KREUSSLER & CO. GMBH
  • TABLE 255 KEY INFORMATION - LGM PHARMA, LLC
  • TABLE 256 KEY INFORMATION - TROIKAA PHARMACEUTICALS LIMITED
  • TABLE 257 KEY INFORMATION - TIANYU CHANG'AN GROUP
  • TABLE 258 KEY INFORMATION -ENDO-FLEX GMBH
  • TABLE 259 KEY INFORMATION - MERZ PHARMA GMBH & CO. KGAA
  • TABLE 260 KEY INFORMATION - MTW-ENDOSKOPIE W. HAAG KG

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH